PFS Partners, LLC - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 45 filers reported holding ATYR PHARMA INC in Q2 2024. The put-call ratio across all filers is 23.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
PFS Partners, LLC ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q2 2024$531
-19.9%
3400.0%0.00%
Q1 2024$663
+38.1%
3400.0%0.00%
Q4 2023$480
-24.1%
340
-15.0%
0.00%
-100.0%
Q3 2023$632
-26.9%
4000.0%0.00%0.0%
Q2 2023$864
+1.3%
400
-1.5%
0.00%0.0%
Q1 2023$853
-4.2%
4060.0%0.00%0.0%
Q4 2022$890
-26.9%
4060.0%0.00%0.0%
Q3 2022$1,218
+6.0%
4060.0%0.00%0.0%
Q2 2022$1,149
-47.1%
4060.0%0.00%
-50.0%
Q1 2022$2,173
-28.4%
4060.0%0.00%0.0%
Q4 2021$3,0334060.00%
Other shareholders
ATYR PHARMA INC shareholders Q2 2024
NameSharesValueWeighting ↓
Checkpoint Capital L.P. 1,446,477$2,820,6301.88%
Tikvah Management LLC 2,460,833$4,798,6241.50%
Logos Global Management LP 3,100,000$6,045,0000.49%
Ghost Tree Capital, LLC 600,000$1,170,0000.32%
Octagon Capital Advisors LP 700,000$1,365,0000.16%
TANG CAPITAL MANAGEMENT LLC 471,134$918,7110.10%
FEDERATED HERMES, INC. 10,169,600$19,830,7200.05%
GSA CAPITAL PARTNERS LLP 224,147$4370.04%
Woodline Partners LP 1,681,279$3,278,4940.03%
Pale Fire Capital SE 91,232$177,9020.02%
View complete list of ATYR PHARMA INC shareholders